BR0109958A - Análogos de didemnina e tamandarina e métodos de preparação e uso deles - Google Patents
Análogos de didemnina e tamandarina e métodos de preparação e uso delesInfo
- Publication number
- BR0109958A BR0109958A BR0109958-2A BR0109958A BR0109958A BR 0109958 A BR0109958 A BR 0109958A BR 0109958 A BR0109958 A BR 0109958A BR 0109958 A BR0109958 A BR 0109958A
- Authority
- BR
- Brazil
- Prior art keywords
- analogs
- methods
- didemnin
- preparation
- tamandarin
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 229930186405 tamandarin Chemical class 0.000 title abstract 3
- KYHUYMLIVQFXRI-XYUQHQMCSA-N (2s)-n-[(2r)-1-[[(3s,6s,8s,12s,13r,16s,17r,20s,23s)-13-[(2s)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino Chemical class CN([C@H](CC(C)C)C(=O)N[C@@H]1C(=O)N[C@@H]([C@H](CC(=O)O[C@H](C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(OC)=CC=2)C(=O)O[C@@H]1C)C(C)C)O)[C@@H](C)CC)C(=O)[C@@H]1CCCN1C(=O)C(C)O KYHUYMLIVQFXRI-XYUQHQMCSA-N 0.000 title abstract 2
- 229930189582 didemnin Natural products 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- OMGHIGVFLOPEHJ-UHFFFAOYSA-N 2,5-dihydro-1h-pyrrol-1-ium-2-carboxylate Chemical group OC(=O)C1NCC=C1 OMGHIGVFLOPEHJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000005623 Carcinogenesis Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000036952 cancer formation Effects 0.000 abstract 1
- 231100000504 carcinogenesis Toxicity 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000001243 protein synthesis Methods 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"ANáLOGOS DE DIDEMNINA E TAMANDARINA E MéTODOS DE PREPARAçãO E USO DELES". A presente invenção refere-se aos análogos de tamandarina, incluindo os análogos de tamandarina e didemnina que tem um resíduo de deoxo-prolina ou um resíduo de deidro-prolina em sua estrutura. Estes análogos são úteis como agentes anti-cânceres e para outros propósitos. O método de preparação destes análogos e métodos de uso deles como inibidores de síntese de proteína, crescimento celular, e tumorigênese e como realçadores de apoptose são da mesma forma fornecidos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/545,848 US6509315B1 (en) | 2000-04-07 | 2000-04-07 | Didemnin analogs and fragments and methods of making and using them |
US09/767,080 US7064105B2 (en) | 2000-04-07 | 2001-01-22 | Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
PCT/US2001/011607 WO2001076616A1 (en) | 2000-04-07 | 2001-04-09 | Tamandarin and didemnin analogs and methods of making and using them |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0109958A true BR0109958A (pt) | 2003-05-27 |
Family
ID=27068046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0109958-2A BR0109958A (pt) | 2000-04-07 | 2001-04-09 | Análogos de didemnina e tamandarina e métodos de preparação e uso deles |
Country Status (17)
Country | Link |
---|---|
US (1) | US7651997B2 (pt) |
EP (1) | EP1276491B9 (pt) |
JP (1) | JP2003535048A (pt) |
AT (1) | ATE339963T1 (pt) |
AU (1) | AU2001251498A1 (pt) |
BR (1) | BR0109958A (pt) |
CA (1) | CA2405779A1 (pt) |
CY (1) | CY1105866T1 (pt) |
DE (1) | DE60123232T2 (pt) |
DK (1) | DK1276491T3 (pt) |
ES (1) | ES2272462T3 (pt) |
IL (1) | IL152111A0 (pt) |
MX (1) | MXPA02009943A (pt) |
NZ (1) | NZ521844A (pt) |
PL (1) | PL358579A1 (pt) |
RU (1) | RU2323000C2 (pt) |
WO (1) | WO2001076616A1 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030148933A1 (en) | 1990-10-01 | 2003-08-07 | Pharma Mar S.A. | Derivatives of dehydrodidemnin B |
GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
MXPA02004862A (es) * | 1999-11-15 | 2003-01-28 | Pharma Mar Sa | Tratamiento de aplidina para canceres. |
US6509315B1 (en) | 2000-04-07 | 2003-01-21 | The Trustees Of The University Of Pennsylvania | Didemnin analogs and fragments and methods of making and using them |
UA76718C2 (uk) | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
CN1479622A (zh) | 2000-10-12 | 2004-03-03 | 联合使用阿普里汀和肌肉保护剂来治疗癌症 | |
RU2341283C2 (ru) | 2003-03-12 | 2008-12-20 | Фарма Мар, С.А. | Усовершенствованное лечение опухолей |
DK1603584T3 (da) | 2003-03-12 | 2009-01-05 | Dana Farber Cancer Inst Inc | Aplidine til behandling af multipelt myelom |
WO2004084812A2 (en) * | 2003-03-21 | 2004-10-07 | Joullie Madeleine M | Tamandarin analogs and fragments thereof and methods of making and using |
PL2029155T3 (pl) | 2006-02-28 | 2016-09-30 | Ulepszony sposób leczenia szpiczaka mnogiego | |
CA2703024A1 (en) * | 2007-10-19 | 2009-04-23 | Giuseppe Longo Sorbello | Improved antitumoral treatments |
KR20100131474A (ko) * | 2008-03-07 | 2010-12-15 | 파르마 마르 에스.에이. | 개선된 항암치료 |
WO2010009334A1 (en) | 2008-07-17 | 2010-01-21 | Colorado State University Research Foundation | Method for preparing largazole analogs and uses thereof |
WO2011020913A2 (en) | 2009-08-21 | 2011-02-24 | Pharma Mar, S.A. | Cyclodepsipeptide antiviral compounds |
WO2013041969A2 (en) | 2011-09-21 | 2013-03-28 | King Abdullah University Of Science And Technology | Didemnin biosynthetic gene cluster in tistrella mobilis |
AU2016229324B2 (en) | 2015-03-06 | 2020-01-16 | Colorado State University Research Foundation | Method for preparing largazole analogs and uses thereof |
AU2016230008B2 (en) | 2015-03-06 | 2020-08-27 | Colorado State University Research Foundation | Synthesis and utility of new capgroup largazole analogs |
JP2019064920A (ja) * | 2016-02-16 | 2019-04-25 | 国立大学法人東北大学 | 環状デプシペプチド化合物 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
US20230158104A1 (en) | 2020-03-02 | 2023-05-25 | Pharma Mar, S.A. | Compounds for use in autoimmune conditions |
UY39110A (es) | 2020-03-02 | 2021-09-30 | Pharma Mar Sa | Compuestos para su uso en infecciones víricas |
BR112022017008A2 (pt) | 2020-03-02 | 2022-10-11 | Pharma Mar Sa | Compostos para uso no tratamento de infecção por coronavírus |
WO2024165764A1 (en) | 2023-02-10 | 2024-08-15 | Pharma Mar, S.A. | Plitidepsin for use in the treatment of non-integrated dna viral infections |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4493796A (en) | 1980-09-12 | 1985-01-15 | Board Of Trustees, Univ. Of Ill. | Didemnins A, B, C, and derivatives thereof, as antiviral agents |
US4782135A (en) | 1980-09-12 | 1988-11-01 | Board Of Trustees, University Of Illinois | Composition of matter and process |
US5137870A (en) | 1980-09-12 | 1992-08-11 | The Board Of Trustees Of The University Of Illinois | Didemnins and nordidemnins |
DE4120327A1 (de) | 1991-06-20 | 1992-12-24 | Basf Ag | Neue peptide, ihre herstellung und verwendung |
ES2102322B1 (es) | 1995-07-13 | 1998-03-01 | Pharma Mar Sa | Procedimiento de preparacion de didemnina a. |
ATE321773T1 (de) | 1996-10-24 | 2006-04-15 | Univ Illinois | Semisynthetisches verfahren zur herstellung von didemninanalogen |
AU726146B2 (en) | 1996-10-24 | 2000-11-02 | Board Of Trustees Of The University Of Illinois, The | Total synthesis of the amino hip analogue of didemnin A |
US6509315B1 (en) | 2000-04-07 | 2003-01-21 | The Trustees Of The University Of Pennsylvania | Didemnin analogs and fragments and methods of making and using them |
UA76718C2 (uk) | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
WO2004084812A2 (en) | 2003-03-21 | 2004-10-07 | Joullie Madeleine M | Tamandarin analogs and fragments thereof and methods of making and using |
-
2001
- 2001-04-09 CA CA002405779A patent/CA2405779A1/en not_active Abandoned
- 2001-04-09 ES ES01924886T patent/ES2272462T3/es not_active Expired - Lifetime
- 2001-04-09 DK DK01924886T patent/DK1276491T3/da active
- 2001-04-09 PL PL01358579A patent/PL358579A1/xx not_active IP Right Cessation
- 2001-04-09 BR BR0109958-2A patent/BR0109958A/pt not_active IP Right Cessation
- 2001-04-09 MX MXPA02009943A patent/MXPA02009943A/es active IP Right Grant
- 2001-04-09 EP EP01924886A patent/EP1276491B9/en not_active Expired - Lifetime
- 2001-04-09 JP JP2001574132A patent/JP2003535048A/ja active Pending
- 2001-04-09 AT AT01924886T patent/ATE339963T1/de not_active IP Right Cessation
- 2001-04-09 IL IL15211101A patent/IL152111A0/xx unknown
- 2001-04-09 WO PCT/US2001/011607 patent/WO2001076616A1/en active Application Filing
- 2001-04-09 RU RU2002129885/15A patent/RU2323000C2/ru active
- 2001-04-09 DE DE60123232T patent/DE60123232T2/de not_active Expired - Fee Related
- 2001-04-09 AU AU2001251498A patent/AU2001251498A1/en not_active Abandoned
- 2001-04-09 NZ NZ521844A patent/NZ521844A/en unknown
-
2006
- 2006-06-20 US US11/455,937 patent/US7651997B2/en not_active Expired - Fee Related
- 2006-12-20 CY CY20061101824T patent/CY1105866T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
RU2002129885A (ru) | 2004-03-27 |
RU2323000C2 (ru) | 2008-04-27 |
US7651997B2 (en) | 2010-01-26 |
ES2272462T3 (es) | 2007-05-01 |
DE60123232D1 (de) | 2006-11-02 |
NZ521844A (en) | 2004-07-30 |
CY1105866T1 (el) | 2011-02-02 |
US20070129289A1 (en) | 2007-06-07 |
MXPA02009943A (es) | 2003-04-25 |
EP1276491A4 (en) | 2004-08-25 |
EP1276491A1 (en) | 2003-01-22 |
IL152111A0 (en) | 2003-07-31 |
EP1276491B1 (en) | 2006-09-20 |
JP2003535048A (ja) | 2003-11-25 |
AU2001251498A1 (en) | 2001-10-23 |
EP1276491B9 (en) | 2007-02-28 |
CA2405779A1 (en) | 2001-10-18 |
DE60123232T2 (de) | 2007-11-08 |
ATE339963T1 (de) | 2006-10-15 |
PL358579A1 (en) | 2004-08-09 |
WO2001076616A1 (en) | 2001-10-18 |
DK1276491T3 (da) | 2007-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0109958A (pt) | Análogos de didemnina e tamandarina e métodos de preparação e uso deles | |
BR0007875A (pt) | Uso de um antagonista de integrina para inibir crescimento de tumor cerebral | |
BR0213877A (pt) | Compostos orgânicos | |
BR9912975A (pt) | Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso | |
BRPI0410164A (pt) | composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano | |
YU159991A (sh) | Postupak za dobijanje u vodi rastvornih analoga kamptotecina i intermedijera za njihovu proizvodnju kao i jedinjenja dobijena ovim postupkom | |
CY1112139T1 (el) | Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης | |
BG66085B1 (bg) | Фенилаланинови производни | |
BR9911682A (pt) | Metano sulfonato de paroxetina | |
BR0116452A (pt) | Composto, composição farmacêutica, uso de um composto | |
BRPI0410705A (pt) | forma cristalina de agonista de receptor 2 adrenérgico | |
AR026275A1 (es) | Compuestos farmaceuticos | |
BRPI0514411A (pt) | formulação, e, método de produzir uma formulação | |
EA200100154A1 (ru) | Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств | |
Báez et al. | A heterodontosaurid ornithischian dinosaur from the Upper Triassic of Patagonia | |
BR0211761A (pt) | depsipeptìdeos e processos para preparar os mesmos | |
ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
BR0311491A (pt) | Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero | |
Deshmukh et al. | Role of calcium in the phenotypic expression of rabbit articular chondrocytes in culture | |
Company et al. | Long bone histology of a eusuchian crocodyliform from the Upper Cretaceous of Spain: Implications for growth strategy in extinct crocodiles | |
BR0211030A (pt) | Derivado de pirrolidina oxadiazole, uso de um derivado de pirrolidina oxadiazole, composição farmacêutica contendo pelo menos um derivado de pirrolidina oxadiazole, método para preparação de um composto de pirrolidina oxadiazole | |
CR7672A (es) | Metodo microbiologico para la produccion de 11- alfa- hidroxiesteroides 7- alfa sustituidos | |
BR9912816A (pt) | Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos | |
AU2001235761A1 (en) | Diagnosis of breast cancer using bcmp-11 as marker | |
AR043037A1 (es) | Benzo [1,2,5] tiadiazoles y su uso farmaceutico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012. |